Observational studyBMC pulmonary medicine2026

Nintedanib for progressive pulmonary fibrosis in real-world setting: an observational study comparing outcomes with an IPF cohort.

Giuseppe Muscato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.